These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37918267)

  • 1. Identification of Key DNA methylation sites related to differentially expressed genes in Lung squamous cell carcinoma.
    Gao J; Feng Y; Yang Y; Shi Y; Liu J; Lin H; Zhang L
    Comput Biol Med; 2023 Dec; 167():107615. PubMed ID: 37918267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
    Wang X; Wang X; Li X; Chang Y
    J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
    Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
    Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
    Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
    BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
    Li Q; Hou J; Hu Z; Gu B; Shi Y
    Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of downregulated ADARB1 in lung squamous cell carcinoma.
    Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
    Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer.
    Cho JW; Shim HS; Lee CY; Park SY; Hong MH; Lee I; Kim HR
    Exp Mol Med; 2022 Jan; 54(1):12-22. PubMed ID: 34987166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.
    Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S
    Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
    Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
    J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K; Wu Y
    BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
    Wang W; Wang S; Chu X; Liu H; Xiang M
    J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma.
    Yang X; Wang C; Nie H; Zhou J; He X; Ou C
    Aging (Albany NY); 2022 Nov; 14(22):9167-9185. PubMed ID: 36445337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma.
    Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L
    PeerJ; 2022; 10():e13057. PubMed ID: 35356464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
    Wang X; Shang W; Chang Y; Li X
    J Comput Biol; 2018 Oct; 25(10):1161-1169. PubMed ID: 30059254
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang W; Li T; Hu B; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.